Filter
903
Text search:
DNA
Featured
Recommendations
102
New Publications
236
Language
Document type
No document type
523
Studies & Reports
122
Guidelines
122
Manuals
54
Fact sheets
34
Strategic & Response Plan
21
Training Material
14
Resource Platforms
5
Situation Updates
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
76
Global
24
Kenya
22
Tanzania
21
Zambia
19
Malawi
17
Western and Central Europe
17
Ethiopia
16
South Africa
16
Nepal
15
Germany
15
Bangladesh
14
Brazil
13
Africa
13
Mozambique
12
Indonesia
11
Latin America and the Carribbean
11
Nigeria
10
Ghana
10
Uganda
9
Namibia
9
Zimbabwe
8
Philippines
8
Rwanda
7
Paraguay
7
Syria
6
Lesotho
6
Asia
6
Liberia
5
Argentina
5
Myanmar / Burma
5
Senegal
4
USA
4
Eswatini/ Swaziland
4
Botswana
4
Angola
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe
4
Sierra Leone
3
Congo, Democratic Republic of
3
Cameroon
3
Cambodia
3
Thailand
3
Venezuela
3
Burkina Faso
2
Haiti
2
Pakistan
2
Iraq
2
Lebanon
2
Peru
2
Ukraine
2
Bolivia
2
Madagascar
2
East and Southern Africa
2
United Kingdom
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Togo
1
Somalia
1
South Sudan
1
Afghanistan
1
Turkey
1
Chad
1
China
1
Colombia
1
Yemen
1
South–East Asia Region
1
Mongolia
1
Timor Leste/ East Timor
1
Russia
1
Vietnam
1
North America
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
124
Pharmacy & Technologies
33
Public Health
32
Women & Child Health
26
Key Resources
24
Capacity Building
12
Toolboxes
HIV
89
TB
88
NTDs
67
COVID-19
50
Mental Health
33
AMR
31
Rapid Response
30
Refugee
25
Planetary Health
22
Pharmacy
16
Caregiver
15
NCDs
14
Ebola
12
Natural Hazards
11
Specific Hazards
9
Cholera
7
Conflict
7
Zika
7
Global Health Education
6
Disability
3
Polio
3
Social Ethics
2
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e
...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re
...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or
...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The
...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the
...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d
...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm
...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s
...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati
...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan
...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po
...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv
...
Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic anima
...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World
...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades.
...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the
...
